Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Propolis anti-inflammatory effects on MAGE-1 and retinoic acid-treated dendritic cells and on Th1 and T regulatory cells. | J Venom Anim Toxins Incl Trop Dis | 2023 | 36721426 | PubTator, text mining | PubMed |
| Therapeutic cancer vaccination against telomerase: clinical developments in melanoma. | Curr Opin Oncol | 2023 | 36700456 | PubTator, text mining | PubMed |
| The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer. | Int J Mol Sci | 2023 | 36675020 | PubTator, text mining | PubMed |
| Advances of mRNA vaccine in tumor: a maze of opportunities and challenges. | Biomark Res | 2023 | 36650562 | PubTator, text mining | PubMed |
| Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population. | J Clin Endocrinol Metab | 2023 | 36611251 | PubTator, text mining | PubMed |
| Activated T cell therapy targeting glioblastoma cancer stem cells. | Sci Rep | 2023 | 36604465 | PubTator, text mining | PubMed |
| The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer. | Thorac Cancer | 2023 | 36594104 | PubTator, text mining | PubMed |
| A library of cancer testis specific T cell receptors for T cell receptor gene therapy. | Mol Ther Oncolytics | 2023 | 36589698 | PubTator, text mining | PubMed |
| Advanced T and Natural Killer Cell Therapy for Glioblastoma. | J Korean Neurosurg Soc | 2023 | 36588388 | PubTator, text mining | PubMed |
| Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions. | Cancer Med | 2023 | 36464889 | PubTator, text mining | PubMed |
| Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review). | Int J Oncol | 2023 | 36367187 | PubTator, text mining | PubMed |
| SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection. | J Thorac Oncol | 2023 | 36243387 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia. | Blood Adv | 2023 | 35984639 | PubTator, text mining | PubMed |
| Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises. | Explor Target Antitumor Ther | 2022 | 36654823 | PubTator, text mining | PubMed |
| Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation. | Front Immunol | 2022 | 36618423 | PubTator, text mining | PubMed |
| New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? | Int J Mol Sci | 2022 | 36613878 | PubTator, text mining | PubMed |
| Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates. | Int J Mol Sci | 2022 | 36613491 | PubTator, text mining | PubMed |
| The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy. | Cells | 2022 | 36611821 | PubTator, text mining | PubMed |
| Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology. | Medicina (Kaunas) | 2022 | 36557005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=9